Dialysate leukocytes, sICAM-1, hyaluronan and IL-6: Predictors of outcome of peritonitis?

Blood Purification

Volumn 22, Issue 4, 2004, Pages 360-366

  Martikainen, Terhi A ^a   Ekstrand, Agneta V ^a,b   Honkanen, Eero O ^a   Teppo, Anna Maija ^a   Grönhagen Riska, Carola ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Department of Medicine   (Finland)

Author keywords

Adhesion molecule; Cytokines; Growth factors; Hyaluronan; Interleukin 6; Peritonitis; Peritonitis outcome; sICAM 1

Indexed keywords

ANTIBIOTIC AGENT; CEFALOTIN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; NETILMICIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DIALYSATE; FEMALE; HUMAN; KIDNEY FAILURE; LEUKOCYTE; MALE; MEASUREMENT; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; TREATMENT OUTCOME;

EID: 4444269036     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080032     Document Type: Article

References (28)

1. Andreoli SP, Leiser J, Warady BA, Schlichting L, Brewer ED, Watkins SL: Adverse effect of peritonitis on peritoneal membrane function in children on dialysis. Pediatr Nephrol 1999;13:1-6.
2. Boeschoten EW: Long-term consequences of peritonitis. Perit Dial Int 1996;16:S349-S354.
3. Davies SJ, Bryan J, Phillips L, Russell GI: Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996;11:498-506.
4. Topley N: Membrane longevity in peritoneal dialysis: Impact of infection and bio-incompatible solutions. Adv Renal Replace Ther 1998;5:179-184.
5. Viglino G, Cancarini G, Catizone L, Cocchi R, de Vecchi A, Lupo A, Salomone M, Segolini GP, Giangrande A: The impact of peritonitis on CAPD results. Adv Perit Dial 1992;8:269-275.
6. Betjes MG, Visser CE, Zemel D, Tuk CW, Struijk DG, Krediet RT, Arisz L, Beelen RH: Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis. Perit Dial Int 1996;16:385-392.
7. Ko YC, Mukaida N, Kasahara T, Muto S, Matsushima K, Kusano E, Asano Y, Itoh Y, Yamagishi Y, Kawai T: Specific increase in interleukin-8 concentrations in dialysis fluid of patients with peritonitis receiving continuous ambulatory peritoneal dialysis. J Clin Pathol 1995;48:115-119.
8. Koziol-Montewka M, Ksiazek A, Janicka L, Baranowicz I: Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis. Inflamm Res 1997;46:132-136.
9. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC: Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000;35:644-652.
10. Brauner A, Hylander B, Wretlind B: Tumor necrosis factor-α, interleukin-1β, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996;27:402-408.
11. Beavis MJ, Williams JD, Hoppe J, Topley N: Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int 1997;51:205-215.
12. Perfumo F, Altieri P, Degl'Innocenti ML, Ghiggeri GM, Caridi G, Trivelli A, Gusmano R: Effects of peritoneal effluents on mesothelial cells in culture: Cell proliferation and extracellular matrix regulation. Nephrol Dial Transplant 1996;11:1803-1809.
13. Teppo AM, Metsärinne K, Fyhrquist F: Radioimmunoassay of interleukin-6 in plasma. Clin Chem 1991;37:1691-1695.
14. Martikainen T, Ekstrand A, Honkanen E, Teppo AM, Grönhagen-Riska C: Cytokines and other soluble factors in dialysate - Indicators of altered peritoneal function? Scand J Nephrol Urol 2002;36:450-454.
15. Rothlein R, Mainolfi E, Czajkowski M, Marlin SD: A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3588-3793.
16. Van der Stolpe A, van der Saag P: Intercellular adhesion molecule-1. J Mol Med 1996;74:13-33.
17. Teppo AM, von Willebrand E, Honkanen E, Ahonen J, Grönhagen-Riska C: Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation: The origin and role of urinary sICAM-1? Transplantation 2001;71:1113-1119.
18. Laurent TC, Fraser JRE: Hyaluronan. Faseb J 1992;6:2397-2404.
19. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Huang CC, Kawaguchi Y, Piraino B, Riella M, Schaefer F, Vas S: Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996;16:557-573.
20. Lalla M, Eklund B, Ahonen J: The clinical significance of c-reactive protein after renal transplantation. Transplant Proc 1988;20:420-404.
21. Heimburger O, Wang T, Lindholm B: Alterations in water and solute transport with time on peritoneal dialysis. Perit Dial Int 1999;19:S83-90.
22. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990;38:495-506.
23. Wang T, Heimburger O, Waniewski J, Bergstrom J, Lindholm B: Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998;13:1242-1249.
24. Wang T, Heimburger O, Cheng HH, Bergstrom J, Lindholm B: Does a high peritoneal transport rate reflect a state of chronic inflammation? Perit Dial Int 1999;19:17-22.
25. Pecoits-Filho R, Araujo MR, Lindholm B, Stenvinkel P, Abensur H, Romao JE Jr, Marcondes M, De Oliveira AH, Noronha IL: Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002;17:1480-1486.
26. Lu Y, Hylander B, Brauner A: Interleukin-10, interferon-γ, interleukin-2, and soluble interleukin-2α receptor detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1996;16:607-612.
27. 1 and basic fibroblast growth factor in patients on CAPD: A study during non-infected steady state and peritonitis. Inflammation 1999;23:131-139.
28. Zemel D, Krediet RT, Koomen GC, Kortekaas WM, Geertzen HG, ten Berge RJ: Interleukin-8 during peritonitis in patients treated with CAPD: An in-vivo model of acute inflammation. Nephrol Dial Transplant 1994;9:169-174.